Neuronetics/$STIM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuronetics
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Ticker
$STIM
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Employees
716
Website
Neuronetics Metrics
BasicAdvanced
$290M
-
-$1.22
1.92
-
Price and volume
Market cap
$290M
Beta
1.92
52-week high
$5.92
52-week low
$3.11
Average daily volume
1M
Financial strength
Current ratio
2.442
Quick ratio
1.901
Long term debt to equity
196.342
Total debt to equity
208.793
Interest coverage (TTM)
-5.12%
Profitability
EBITDA (TTM)
-35.784
Gross margin (TTM)
64.18%
Net profit margin (TTM)
-54.23%
Operating margin (TTM)
-42.61%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
-19.38%
Return on equity (TTM)
-144.50%
Valuation
Price to revenue (TTM)
1.95
Price to book
8.15
Price to tangible book (TTM)
-119.21
Price to free cash flow (TTM)
-4.678
Free cash flow yield (TTM)
-21.38%
Free cash flow per share (TTM)
-0.938
Growth
Revenue change (TTM)
22.16%
Earnings per share change (TTM)
28.63%
3-year revenue growth (CAGR)
16.07%
3-year earnings per share growth (CAGR)
-2.61%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neuronetics stock?
Neuronetics (STIM) has a market cap of $290M as of August 01, 2025.
What is the P/E ratio for Neuronetics stock?
The price to earnings (P/E) ratio for Neuronetics (STIM) stock is 0 as of August 01, 2025.
Does Neuronetics stock pay dividends?
No, Neuronetics (STIM) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Neuronetics dividend payment date?
Neuronetics (STIM) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuronetics?
Neuronetics (STIM) has a beta rating of 1.92. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.